Buck MB - Search Results

1

Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.

Joffroy CM, Buck MB, Stope MB, Popp SL, Pfizenmaier K, Knabbe C. Joffroy CM, et al. Among authors: buck mb. Cancer Res. 2010 Feb 15;70(4):1314-22. doi: 10.1158/0008-5472.CAN-09-3292. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145137

2

Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients.

Buck MB, Fritz P, Dippon J, Zugmaier G, Knabbe C. Buck MB, et al. Clin Cancer Res. 2004 Jan 15;10(2):491-8. doi: 10.1158/1078-0432.ccr-0320-03. Clin Cancer Res. 2004. PMID: 14760070

3

Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.

Buck MB, Pfizenmaier K, Knabbe C. Buck MB, et al. Mol Endocrinol. 2004 Jul;18(7):1643-57. doi: 10.1210/me.2003-0278. Epub 2004 Mar 31. Mol Endocrinol. 2004. PMID: 15056732

4

Smad4-expression is decreased in breast cancer tissues: a retrospective study.

Stuelten CH, Buck MB, Dippon J, Roberts AB, Fritz P, Knabbe C. Stuelten CH, et al. Among authors: buck mb. BMC Cancer. 2006 Jan 26;6:25. doi: 10.1186/1471-2407-6-25. BMC Cancer. 2006. PMID: 16438724 Free PMC article.

5

A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.

Beisner J, Buck MB, Fritz P, Dippon J, Schwab M, Brauch H, Zugmaier G, Pfizenmaier K, Knabbe C. Beisner J, et al. Among authors: buck mb. Cancer Res. 2006 Aug 1;66(15):7554-61. doi: 10.1158/0008-5472.CAN-06-0634. Cancer Res. 2006. PMID: 16885354

6

TGF-beta signaling in breast cancer.

Buck MB, Knabbe C. Buck MB, et al. Ann N Y Acad Sci. 2006 Nov;1089:119-26. doi: 10.1196/annals.1386.024. Ann N Y Acad Sci. 2006. PMID: 17261761 Review.

7

TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.

Buck MB, Coller JK, Mürdter TE, Eichelbaum M, Knabbe C. Buck MB, et al. Breast Cancer Res Treat. 2008 Jan;107(1):15-24. doi: 10.1007/s10549-007-9526-7. Epub 2007 Feb 15. Breast Cancer Res Treat. 2008. PMID: 18043895

8

Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.

Stope MB, Popp SL, Knabbe C, Buck MB. Stope MB, et al. Among authors: buck mb. Breast Cancer Res Treat. 2010 Apr;120(2):357-67. doi: 10.1007/s10549-009-0393-2. Epub 2009 Apr 16. Breast Cancer Res Treat. 2010. PMID: 19370415

9

Antiestrogens suppress effects of transforming growth factor-β in breast cancer cells via the signaling axis estrogen receptor-α and Y-box Binding Protein-1.

Popp SL, Joffroy C, Stope MB, Buck MB, Fritz P, Knabbe C. Popp SL, et al. Among authors: buck mb. Anticancer Res. 2013 Jun;33(6):2473-80. Anticancer Res. 2013. PMID: 23749898

10

Y-box Binding Protein-1 Enhances Oncogenic Transforming Growth Factor β Signaling in Breast Cancer Cells via Triggering Phospho-Activation of Smad2.

Stope MB, Weiss M, Koensgen D, Popp SL, Joffroy C, Mustea A, Buck MB, Knabbe C. Stope MB, et al. Among authors: buck mb. Anticancer Res. 2017 Dec;37(12):6745-6748. doi: 10.21873/anticanres.12134. Anticancer Res. 2017. PMID: 29187452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters